Cardiorenal interactions in heart failure: insights from recent therapeutic advances - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/37364186/
Heart failure is a syndrome that may develop when cardiovascular disease progresses or is insufficiently treated and associated with a poor quality of life, high mortality rates, and increased healthcare...
New therapies, including SGLT2 inhibitors, GLP-1 receptor agonists, and non-steroidal MRAs, enhance cardiovascular and renal outcomes in high-risk patients with diabetes and heart failure, significantly improving patient management.
Feasibility of a digital palliative care intervention (Convoy-Pal) for older adults with heart failure and multiple chronic conditions and their caregivers: a waitlist randomized control trial
Source : https://pubmed.ncbi.nlm.nih.gov/39354453/
ClinicalTrials.gov Identifier NCT04779931. Date of registration: March 3, 2021.
The Convoy-Pal intervention demonstrated feasibility and potential benefits for heart failure patients and their caregivers, highlighting the need for digital tools that effectively integrate both parties in palliative care.
Efficacy of catheter ablation for atrial fibrillation in heart failure: a meta-analysis of randomized controlled trials
Source : https://pubmed.ncbi.nlm.nih.gov/38661235/
The study aims to evaluate whether rhythm control by catheter ablation is superior to medical therapy for the patients with atrial fibrillation (AF) and heart failure (HF). The literatures were...
Catheter ablation significantly improves survival, reduces heart failure re-hospitalization, enhances left ventricular function, and quality of life in atrial fibrillation patients with heart failure compared to medical therapy.
Systematic review and meta-analysis of stroke and thromboembolism risk in atrial fibrillation with preserved vs. reduced ejection fraction heart failure - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/39289613/
The findings suggest that there is no significantly different risk of stroke and systemic thromboembolism in cases of AF with associated HFpEF or HFrEF. The finding does not support integration...
This study found no significant difference in stroke and thromboembolism risk between atrial fibrillation patients with preserved or reduced ejection fraction, suggesting ejection fraction shouldn't factor into stroke risk assessments.
A comparison of heart failure patients with reduced ejection fraction in the Moravian Midlands Registry with the LCZ696 patients in the Paradigm-HF trial - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/36748670/
The differences between the groups for the majority of clinical parameters compared were minimal, except for younger age, higher body mass index and serum creatinine level and lower left ventricular...
A study compared heart failure patients in the Moravian Midlands Registry with Paradigm-HF trial participants, revealing younger age, higher BMI, lower ejection fraction, and more device therapies in the MMR cohort.